GCT is taking part in the CTAD Alzheimer Congress
GCT President, Dr. Jeffrey Apter is participating at the 13th Clinical Trials on Alzheimer’s Disease Congress (CTAD) which is held from 4th to 7th of November.
The congress brings worldwide leaders in the treatment of Alzheimer’s disease together, and is a perfect platform to share their expertise in the research of Alzheimer’s disease. Dr. Apter is KOL in psychiatry and has over 30 years of experience in clinical research focusing on Alzheimer’s disease.
Reach out to us at email@example.com if you would like to set up a meeting.
Updated: October 21, 2020